One Last Note for 2017 From Our Programming Staff

Let’s face it, not everyone has their career goals set for being a programmer. However, if you google “why you should learn programming” you will find numerous articles that say it is the professional expertise that all leaders in business should know how to do or at the very least understand the value of having this skillset.

Heading into a new year can bring a mixed bag of emotions for many; some are happy to turn the page, others are anxious for what the future brings, and some reflect on accomplishments and growth.

For those working in the CRO industry, we thought we’d share what some of our most dedicated programming staff with DataCeutics thought about their work throughout 2017.

Greg Weber, Principal Consultant - “What I really liked was continuing to work with the client to implement and support their computing systems and processes. My favorite part is providing training, individual support and troubleshooting. I get to meet lots of folks and help them resolve whatever issue they are encountering. It could be as simple as unlocking their account or a more complicated issue, it still gives me satisfaction to end the communication knowing they can get back to work.”

Cheryl Fournier, Office Manager & Special Assistant to the CEO wanted to get in on this as well. She said, “The thing I enjoy most about my job is the teamwork approach to projects where we can all contribute to make a difference in the lives of people who need medical intervention and improve or save their life. It’s an awesome feeling receiving an accolade from a client for the efforts of my colleagues in getting a drug to market. I am honored to work with such a talented and dedicated group of people."

Matt Ferdock, CEO of DataCeutics added, “This past year has been a growth year, not only growth in business but in the way our company continues to address and develop skill sets that match the future business environment. Staying abreast of our clients’ needs and adapting to such a rapidly changing business environment is a challenge we continue to stand up to and offer tools and services that meet these challenges."

Kathy Greer, Senior Vice President Professional Services especially wanted to acknowledge the Recruiting practice that plays a daily role in the operations of DataCeutics. Kathy said, “Recruiting is challenging when matching clients’ needs and finding the right person to fill the job. We’re fortunate in that our internal staff provides us the candidates, many times, through our referral program. Great programmers associate themselves with other great programmers!”

Steve Light, Executive Director Professional Services adds, “It is great to reflect back on the CDISC projects we helped get processed. It by far wasn’t easy, but because we worked hard to train our staff to be ready for these projects needing SDTM and ADaM experience, our team made a difference for many companies with their submissions. I look forward to doing even more in 2018."

Paul Gilbert, President of DataCeutics added, “Operationally, I have watched the teams of programmers exceed our customers’ expectations and this is so evident in the many expressions of appreciation we received from customers throughout 2017 about our programmers’ dedication to their work. Many times, we pull the “rabbit out of the hat” so that we keep the work going while our customers face challenges that we help to solve. It’s very rewarding to see that the service organization both Matt, my partner and I have created truly fills a human-interest need by helping drug developers create good medicine for those in need.”

Stephanie Perez, Lead Programmer shared, “I loved working with various teams from the client company and DataCeutics. It was a pleasure to work with so many professional and knowledgeable people. I also loved doing the programming since that is my passion. I enjoyed learning new techniques and efficiencies and always strove to improve my skills. Most importantly, I was honored to work on clinical trials for rare, life-threatening diseases to help get life-changing therapies to patients who so desperately need them. It was humbling to be part of that process.